This study reported the synthesis, the binding assays on 5-HT1A receptors and the biological evaluation against prostate and breast cancer cell lines of a novel class of thiazolinylphenyl-piperazines that has never been described before. The gene discussed is HTR1A; the disease is breast carcinoma.